GYRE- Gyre Therapeutics, Inc.
Gyre Therapeutics, Inc. (GYRE) has 6 insiders with recent SEC Form 4 filings, including 6 buys and 7 sells. GYRE is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.57M | $15.72M | - | |
| 10% | 2.14M | $13.14M | - | |
| CFO | 95.1K | $582.7K | - | |
| Dir | 52.0K | $318.8K | - | |
| CFO | 50.0K | $306.5K | - |
Activity
Buys and sells only
Transactions
9 filings · page 7
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2020 | Williams Eddie | Director | Buy | 2,000 | $5.78 | $11,560.00 | +22.6% | |
| Feb 25, 2020 | Lawlor Augustine | Director | Sell | 69,401 | $6.10 | $423,505.72 | -100% | |
| Feb 25, 2020 | Ling Geoffrey M.D. | Director | Buy | 3,000 | $6.23 | $18,691.50 | New | |
| May 24, 2019 | Richard John P | Director | Buy | 1,000 | $8.03 | $8,030.00 | +463.0% | |
| Nov 16, 2018 | Levy Howard | Chief Medical Officer | Sale+OE | 173 | $11.00 | $1,903.00 | -2.2% | |
| Mar 8, 2018 | Flynn James E62 | 10% Owner, Possible Member Of 10% Group | Sell | 71,778 | $30.53 | $2,191,045.03 | -1.3% | |
| Dec 17, 2015 | Usman Nassim67 | President &CEO | Buy | 4,000 | $2.00 | $8,000.00 | +5.4% | |
| Dec 17, 2015 | Payne Fletcher | Chief Financial Officer | Buy | 10,000 | $2.00 | $20,000.00 | +66.5% | |
| Dec 17, 2015 | Hill Stephen A | Director | Buy | 5,000 | $2.03 | $10,150.00 | +31.8% |
← PrevPage 7